Rapid development of myeloproliferative neoplasm in mice with Ptpn11D61Y mutation and haploinsufficient for Dnmt3a.

Oncotarget
Lisa DengReuben Kapur

Abstract

PTPN11 gain-of-function mutation is the most common mutation found in patients with juvenile myelomonocytic leukemia and DNMT3A loss occurs in over 20% of acute myeloid leukemia patients. We studied the combined effect of both Ptpn11 gain-of-function mutation (D61Y) and Dnmt3a haploinsufficiency on mouse hematopoiesis, the presence of which has been described in both juvenile myelomonocytic leukemia and acute myeloid leukemia patients. Double mutant mice rapidly become moribund relative to any of the other genotypes, which is associated with enlargement of the spleen and an increase in white blood cell counts. An increase in the mature myeloid cell compartment as reflected by the presence of Gr1+Mac1+ cells was also observed in double mutant mice relative to any other group. Consistent with these observations, a significant increase in the absolute number of granulocyte macrophage progenitors (GMPs) was seen in double mutant mice. A decrease in the lymphoid compartment including both T and B cells was noted in the double mutant mice. Another significant difference was the presence of extramedullary erythropoiesis with increased erythroid progenitors in the spleens of Dnmt3a+/-;D61Y mice relative to other groups. Taken together,...Continue Reading

References

Nov 12, 2010·The New England Journal of Medicine·Timothy J LeyRichard K Wilson
Mar 19, 2011·Leukemia·M J WalterT A Graubert
Dec 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Qing YuMark H Kaplan
Nov 27, 2014·The New England Journal of Medicine·Siddhartha JaiswalBenjamin L Ebert
Oct 13, 2015·Nature Genetics·Elliot StieglitzMignon L Loh
Aug 23, 2016·Nature Communications·Andrew L YoungTodd E Druley
Sep 6, 2017·The Journal of Clinical Investigation·Christopher B ColeTimothy J Ley

❮ Previous
Next ❯

Citations

Mar 6, 2019·European Journal of Clinical Pharmacology·Raquel MerinoRosa Terré

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
flow cytometry

Software Mentioned

GraphPad
CellQuest

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban
Ya-Nan LiuMin Xiao
Nature Genetics
Mrinal Y Shah, Jonathan D Licht
© 2022 Meta ULC. All rights reserved